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Abstract. Little is known about how lymphocytes mi.- 
grate within secondary lymphoid organs. Stromal cells 
and their associated reticular fibers form a network of 
fibers that radiate from high endothelial venules to all 
areas of the lymph node and may provide a scaffold for 
lymphocyte migration. We studied interactions of lym- 
phocytes with cultured human tonsillar stromat cells 
and their extracellular matrix using shear stress to dis- 
tinguish transient interactions from firm adhesion. Ton- 
sillar lymphocytes and SKW3 T lymphoma cells teth- 
ered and rolled on monolayers of cultured lonsilla~ 
stromal cells and their matrix. A  significant proportior~ 
of these rolling interactions were independent of diva-. 
lent cations and were mediated by CD44 binding t.:~ 
hyaluronan, as shown by inhibition with mAb lo CD44, 
soluble hyaluronan, hyaluronidase treatme~l of the 
substrate, and O-glycoprotease treatment of the rolling 
cells. O-glycoprotease treatment of the substrate also 
blocked binding completely to stromal matrix and 
partially to stromal monolayers. SKW3 cells tethered 
and rolled on plastic-immobilized hyaluronan, confirm-. 
ing the specificity of this interaction. By contra~,t, 
monolayers of resting or stimulated human umbilical 
vein endothelial cells failed to support CDZ4- ap, d by_ 
aluronan-dependent rolling. SKW3 cells added under 
flow conditions to frozen sections of human tonsil 
bound and rolled along reticular fibers in the presence 
of EDTA. Rolling was blocked by either CD44 mAb or 
hyaluronan. We propose that lymphocytes migrati~g 
through secondary lymphoid organs may use CD,!4 to 
bind to hyaluronan immobilized on stromal ce!!~ a~d 
reticular t~bers. 
M 
osl- studies of lymphocyte recirculation have to 
date  focused on  the  first  step  of this  process, 
namely  extravasation  of lymphocyles through 
high  endothelial venules (HEV)  ~ in secondary lymphoid 
organs.  Little is  known  about how lymphocytes migrate 
within  secondary  lymphoid  tissues.  The  HEV  through 
which lymphocytes gain access to the secondary lymphoid 
organs are located in the interfollicular or T cell areas. Af- 
ter entry, a complex series of events ensues, including mi- 
gration of lymphocytes to different T  and B ceil regions, 
contact between B  and T  lymphocytes and with antigev~- 
presenting cells, and reentry into the circulation via effer- 
ent lymphatics. The B and T cell meas have distinct anti- 
gen-presenting cells, termed follicular dendritic cells and 
interdigitating  dendritic  cells,  respectively.  Both  areas 
bare macrophages. The T cell or interfollicular areas also 
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contain a dense meshwork of fibroblast-like stromaI ceils 
and their associated reticular fibers. The B celt areas con- 
tain  fewer stromaI cells  and  fibers.  Reticular  fibers  are 
composed of extracellular matrix (ECM) and can be visu.. 
alized in tissue sections by silver impregnation. Reticular 
fibers are unique in that they incorporate proteins othe~- 
wise  specific lo basement  membranes  (38). These fibers 
are formed by a core of type III collagen (7, 14, 16, 36, 48) 
surrounded by a coat of the basement membrane-specific 
proteins type IV collagen, laminin, entactin, and heparan 
sulfate  proteoglycan (38).  as well  as  fibronectin  (16, 48, 
70), tenascin (13), vitronectin (76), type i  collagen (7, ld, 
I6, 36,  48), versican, and decorin (unpublished  observa- 
tions). Reticular fibers are continuous with the basal lam- 
ina of HEV and form a network of fibers that radiate fro,~ 
HEV to all areas of the lymph node (14). Stromai cells are 
found  in  close  association  with  these  fibers  and  are 
thought to produce and maintain them (14). Lymphocytes 
also contact retic.ular fibers (6). and it has been hypothe- 
sized that lymphocytes may use these structures as a path- 
way for migration through secondary lymphoid organs (38). 
We have cultured stromal cells from humae tonsil and 
examined their interactions with  lymphocytes. Lympho- 
cytes actively migrating through secondary lymphoid or- 
gans may require adhesive interactions of a more transier!t 
nature than those used by cells firmly anchored in a pattie- 
© The Rockefeller U niversity Press. 0021-9525/96/08/1075/t 3 $2Akq 
The Journal of Celt Biology, Voles,  me 134, Number 4. August 1996 1075-t 087  t 075 ular location. Although significant hydrodynamic flow is 
unlikely to exist outside the vasculature, flow can nonethe- 
less be a powerful tool for discriminating between different 
classes of adhesive interactions. Therefore, we have used 
hydrodynamic flow to distinguish between transient adhe- 
sive interactions that can support roiling and stable adhe- 
sive interactions that support firm attachment on stromal 
cells and matrix. Previous flow studies have demonstrated 
that two classes of molecules are capable of mediating roll- 
ing:  the  selectins,  L-selectin,  P-selectin,  and  E-selectin 
(63), and certain members of the integrin family, i.e., et4137 
that binds to MAdCAM-1 (10), very late antigen (VLA)-4 
that binds to vascular cell adhesion molecule (VCAM)-I 
(2,  10),  and c~6134 that binds to laminin  (75). We report 
here a  novel adhesive mechanism that supports lympho- 
cyte rolling, namely Ca  2+- and Mg2+-independent binding 
of CD44 on tonsillar lymphocytes to hyaluronan (hyalu- 
ronic acid) present on the surface of tonsillar stromal cells 
and incorporated into the ECM. CD44 is a widely distrib- 
uted transmembrane protein with homology to the carti- 
lage  link  proteins  and  can  be  variably spliced  (21,  29). 
CD44  is decorated with N-linked carbohydrate, heparan 
sulfate  and  chondroitin  sulfate  glycosaminoglycans, and 
O-linked mucin and polylactosamine groups  (11). CD44 
binds to hyaluronan (4, 15, 44, 49, 51) and the cytokine os- 
teopontin  (Eta-l)  (77).  CD44  contributes  to  binding  of 
lymphocytes to HEV in frozen section assays in humans 
(34), and thus has been implicated in lymphocyte extrava- 
sation. However, CD44 does not mediate binding to HEV 
in mice (15, 45),  and modulation of CD44 from the cell 
surface has no effect on homing of lymphocytes to lymph 
nodes in vivo (12). We show that areas rich in reticular fibers 
in frozen sections of tonsil support CD44- and hyaluronan- 
dependent rolling, suggesting a role for these molecules in 
lymphocyte adhesive interactions during migration through 
secondary lymphoid organs. 
Materials and Methods 
Culture of Stromal CeUs  from Human Tonsil 
Tonsils obtained from pediatric patients undergoing tonsillectomy (Mas- 
sachusetts General Hospital, Boston, MA) were processed as described 
(26), except that the ceils obtained from the second collagenase treatment 
were cultured without passage though a steel screen. Briefly,  tonsils were 
minced on a steel mesh screen (200 mesh =  74 ~m, Type 316; Tylinter, 
Mentor, OH) and washed with L15 medium (Sigma Chemical,  St. Louis, 
MO) to remove released  lymphocytes. Material  retained  on the screen 
was treated with 0.5%  collagenase (collagenase I, 187 U/rag; Worthington 
Biochemical  Corp., Freehold, N  J) and 1 U/ml DNAse (Promega, Madi- 
son, W1) for 30 rain at 37°C. Material was then minced again and retreated 
with 0.5% collagenase and DNAse for 60 rain at 37°C. The cell suspension 
was washed three times in RPMI  1640 medium (JRH Biosciences,  Len- 
exa, KS), 10%  FBS (JRH Biosciences),  and 5 x  107 cells were seeded in 
10 ml of medium per 150-ram Falcon tissue-culture dishes (Becton Dickin- 
son Labware, Lincoln  Park,  NJ).  Nonadherent cells  were removed on 
days 2 and 4 by rinsing with fresh RPMI 1640, 10% FBS.  Dendritic cells, 
macrophages, endothelial cells, and adherent lymphocytes, identified  by 
morphology and expression of specific  surface markers, were present in 
newly established primary cultures at day 2 but were not present after 5 d. 
Cells  were routinely subcultured up to three times at confluence by re- 
moval with trypsin/EDTA and 1:10 dilution into fresh medium. Cells were 
grown to confluence in six-well  plates for flow studies.  Stromal cells  in 
early passages grew quickly  and formed confluent monolayers, while cells 
passaged four times or more failed  to form monolayers and instead grew 
in clumps. For matrix experiments, confluent monolayers were removed 
with 5 mM EDTA in HBSS at 37°C for 10 min, and wells were rinsed with 
HBSS. 
Isolation of  Lymphocytes  from Human Tonsil 
Lymphocytes were released from tonsil by mincing the tissue on a steel 
mesh screen and rinsing with L15 medium. Ceils that passed through the 
screen were washed three times with RPMI 1640 and 10% FBS, once with 
HBSS and 5 mM EDTA, and resuspended in HBSS, I mM Mg  2+, and 2 mM 
Ca  e÷ for flow experiments. Separation of tonsillar lymphocytes into B and 
T  cell  populations by immunomagnetic-negative selection was done as 
previously described (58) with the substitution of the mAb CD3 (Coulter 
Corp., Hialeah, FL) for the CD20 mAb in purification of B cells. 
Antibodies 
2F3  mAb  (53)  was a  kind  gift  of  R.  Kannagi  (Aichi  Cancer  Center, 
Nagoya, Japan); MECA-79 mAb (71) was a kind gift of E. Butcher (Stan- 
ford University School of Medicine,  Stanford, CA); and PUJ4 (a4 integrin 
mAb) and PUJ5 (aS integrin mAb) ascities were both kindly given by M. 
Hemler (Dana Farber Cancer Institute, Boston, MA). Mab 13  (131 inte- 
grin mAb) was kindly provided by K. Yamada (NIH, Bethesda, MD), and 
GoH3 (a6 integrin mAb) was graciously donated by A. Sonnenberg (Uni- 
versity of Amsterdam, The Netherlands). CBRp150/2E1  (65), recognizing 
P150,95,  was used as a  control mAb in  flow antibody-blocking assays. 
M138 mAb was produced by immunizing mice with human tonsillar stro- 
real preparations and screening the resulting mAb by immunohistochem- 
istry on sections of human tonsil.  The protocol for fusion and hybridoma 
maintenance has been described in detail  (64). M138 recognizes type IV 
collagen,  as evidenced by its immunohistochemical reactivity  pattern and 
recognition of immobilized type IV collagen in dot blots (data not shown). 
All other mAbs were obtained from the Fifth International Workshop on 
Human White Cell  Differentiation Antigens. mAb to ct integrin subunits 
from the Fifth Leukocyte Workshop were IB3.1 (cd), Gi9 (a2), J143 (~3). 
mAb were used for flow cytometry at 5  p.g/ml or at  1:100 dilution for 
workshop mAb. For flow assay mAb-blocking studies, input cells were in- 
cubated 40 rain at 4°C with a 1:20 dilution of rnAb from the Fifth Interna- 
tional Workshop on Leukocyte Differentiation Antigens, a  1:1,000 dilu- 
tion of PUJ4 or PUJ5 ascities,  25 iLg/ml of Mab 13, 50 ixg/ml of CB Rp 150/ 
2El, or neat supernatant of GoH3. 
Flow Experiments 
Cell  tethering and rolling was measured in a parallel-plate flow chamber 
that was placed into one well of a six-well plate (35-mm wells) such that 
cell monolayers or matrix formed the floor of the chamber (35, 42). All ex- 
periments were in HBSS with or without divalent  cations as described. 
Hyaluronic acid  (1 mg/ml or 0.5 mg/ml, 25  t~l vol; Sigma  Chemical Co.) 
was adsorbed on 100 ×  15-mm plastic  petri dishes (Nunc Inc., Naperville, 
IL) overnight at 4°C and blocked with 2% human serum albumin (Calbio- 
chem-Novabiochem Corp., San Diego, CA) for 3 h at 37°C. Video micros- 
copy, analysis  of videotape, measurements of cell accumulation in shear 
flow, and measurement of detachment of ceils and roiling  velocities  were 
as described (42).  Unless otherwise stated, rolling experiments used the 
following shear stresses: cells  were accumulated at .27, .53, .80, and  1.1 
dynes/cm  z for 40 s each, followed by rinsing with cell-free  medium at 1.6, 
2.1, 2.7, 3.7, 4.8, 5.8, 7.9, 10.1, 12.2, 175, 22.8. and 28.1 dynes/cm  ~ for 10 s 
each.  Adherent cells were counted after the .80 dynes/cm  2 accumulation 
step. For a cell to be counted as rolling, it had to roll a distance of at least 
five times the cell diameter. This was determined by marking each cell's 
location at the time of initial attachment, placing a second mark at the site 
of detachment or at the final cell position at the end of the 28.1 dynes/cm  ~ 
step, and then measuring the distance traveled. 
Flow Cytometry 
Flow cytometry was done as previously described (17). 
Enzyme Treatments 
Cells (2 x  10  ~  cells in 200 Ixl) or substrates (in six-well plates overlaid with 
500  ixl of medium) were treated with 0.1  U/ml of neuraminidase (from 
Vibrio  cholerae;  Sigma Chemical Co.), 60 ~g/ml (0.3 U/ml) O-glycopro- 
tease (Accurate Chemical  and Scientific Corp., Westbury, NY), 0.5 U/m] of 
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Co.), or 1,000 U/ml of hyaluronidase (type IV-S from bovine testes; Sigma 
Chemical Co.) diluted in RPMI 1640 and 0.1%  BSA for 40 min at 37°C. 
Soluble Inhibitors 
Chondroitin sulfate B from bovine mucosa (Sigma Chemical Co.), chon- 
droitin sulfate C from shark cartilage (Sigma Chemical Co.) or hyaluronan 
from human umbilical  cord (Sigma Chemical Co.) at 200 Fg/ml, or 5 mM 
EDTA were added to the cell suspension and the flow chamber for 10 min 
before flow experiments and were present throughout the experiments. 
Human Umbilical Vein Endothelial Cell (HUVEC), 
Epithelial, and Dermal Fibroblast Assays 
HUVEC were isolated and cultured as previously described (25, 33). Cells 
were grown to confluence on six-well plates and stimulated with 200 U/ml 
tumor necrosis factor ct (TNF-a) (Genzyme, Boston, MA) for 24 h. Epi- 
dermal cell  line  A-431  (CRL 1555) and dermal fibroblasts (CCD-32Sk) 
were obtained from the American Type Culture  Collection  (Rockville, 
MD) and cultured in six-weU plates in RPMI 1640 and 10% FBS. 
Rolling on Tonsil Sections 
Freshly cut 5-/~m sections of human tonsil were placed on 70  ×  50-mm 
glass slides (Coming Glass Works, Corning, NY) precoated with 0.1 mg/ml 
poly-L-lysine (Sigma Chemical Co.), allowed to dry 1-3 h at room temper- 
ature, and then stored at 4°C for up to 2 h until used. The flow chamber 
was attached directly  to the glass slides. A serial  section was stained with 
collagen type IV mAb M138. Video images were captured using NIH Im- 
age software version 1.59 written by Wayne Rasband, and unbound cells 
were darkened by comparing two consecutive frames and using the mini- 
mum value for each pixel. 
Results 
Tonsillar Lymphocytes Roll on Monolayers of Cultured 
Tonsil Stromal Cells 
Cultured  tonsillar  stromal  cells  of passage  number  1-3 
were grown to confluence on six-well plates and used as a 
rolling  substrate  in  flow  studies.  Freshly  isolated  tonsil 
lymphocytes introduced under flow adhered to the mono- 
layer at a wall shear stress of 0.8 dynes/cm  2, began to roll 
at a  wall shear stress of 1.06  dynes/cm  2, and continued to 
roll as shear was increased. The ability of cells to form roll- 
ing adhesions was only partially inhibited by EDTA (Fig. 1). 
In the continued  presence of EDTA, stromal cells began 
detaching, and tonsil lymphocytes were seen to roll on the 
underlying extracellular matrix. Stromal ECM, produced 
by  removing  confluent  stromal  cells  with  EDTA,  was 
therefore used as an additional rolling substrate in subse- 
quent  experiments  (see  below).  Separation  of  tonsiUar 
lymphocytes into T  and B cell populations by negative se- 
lection  demonstrated  that  both  T  and  B  cells  bound  to 
stromal monolayers under  flow (data  not shown). There 
was significant variability between tonsil lymphocyte prep- 
arations in the number of lymphocytes adhering per field 
and in the amount of inhibition by EDTA, perhaps due to 
variation between the freshness of tissue and the degree of 
activation of lymphocytes in different tonsillar specimens. 
Lymphocytes harvested from tonsil contain activated cells 
that express the  activation antigens  CD26,  CD30,  CD39, 
CD69, CD70, and CD71 (8, 9, 20, 59, 60, 68, 69). Because T 
lymphoblastoid cell lines are  useful models for activated 
lymphocytes, cell lines were also evaluated for their ability 
to  form  rolling  attachments  to  stromal  cell  monolayers 
Figure 1.  Rolling attachments formed by various cell types with 
monolayers of tonsillar stromal cells. Cells were counted after ac- 
cumulating  under flow at a wall shear stress of 0.8 dynes/cm z for 
40 s. When the shear stress was subsequently  increased,  all cells 
rolled. Results are from one representative experiment per donor 
using tonsillar  lymphocytes and the mean values of two experi- 
ments for other cell types. 
(Fig. 1). Jurkat cells and HL-60 cells failed to bind, despite 
the  presence  by flow cytometry of L-selectin  on  Jurkat 
cells and the ability of HL-60 cells to bind to immobilized 
L-selectin  (data  not  shown).  SKW3  cells,  in  contrast, 
bound  to  the  monolayer at  0.8  dynes/cm  2 and  rolled  as 
shear was increased. EDTA inhibited  SKW3 cell binding 
by 32%  (Fig. 1).  When SKW3 cells were pretreated with 
0.1%  azide for 10 min, all cells rolled in a sustained man- 
ner.  Without  azide  treatment,  most  cells  rolled  only  a 
short  distance  before  firmly  attaching.  Azide  treatment 
was included  in  subsequent  experiments to facilitate  ex- 
amination of the rolling component of cell adhesion. 
Tonsillar Stromal Cells Lack Known Selectins and 
Selectin Ligands 
Cultured tonsillar stromal cells were examined by flow cy- 
tometry for their expression of surface molecules (Table I). 
Stromal cells expressed no E-, L- or P-selectin, nor did they 
express  carbohydrate  antigens  associated  with  selectin 
ligands such as sialyl Le  x, sialyl Le  a, CLA, and PNAd. The 
FH6  mAb  did  stain  these  cells,  suggesting  that  stromal 
cells may bear a difucosylated form of sialyl Le  x. However, 
stromal  cells  detached  from  their  substrate  by  EDTA 
failed to form rolling adhesions on E-selectin and L-selectin 
substrates (data not shown), suggesting that this structure 
is not a functional selectin ligand. Stromal cells expressed 
high levels of Thy-1 and CD44, as well as moderate to low 
levels of VLA-4, Limaxflavus agglutinin (LFA)-3, VCAM-1, 
intracellular adhesion molecule (ICAM)-I, and CD21. Stro- 
mal cultures  were negative for B  cell, T  cell,  and  mono- 
cyte/macrophage markers showing lack of contamination 
with these cell types. 
Enzymatic Sensitivity of Rolling Interactions 
To study the nature of the rolling interactions, SKW3 and 
stromal  cell monolayers and  matrix were  treated  with  a 
panel of glycosidases and proteases before their use in flow 
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by Flow Qvtornetry 
...................................................................... 
Antigen  CD assignment  mAb  Mean fluorescence 
LFA- 1  CD 11 a  TS 1/22  2 A 
Mac-I  CDI lb  CBRM1/29.1  -0.8 
p 150,95  CD 11 c  CBRp 150/2E 1  -  0.4 
ICAM- I  CD54  CBR-IC 1/11.2  20.(I 
ICAM-2  CD102  CBR-1C2/2  1.1 
ICAM-3  CD50  CBR-IC3/I  -  1  3 
VCAM- 1  CD 106  E 1/6  31.0 
VLA-4  CD49d  611  110.0 
LFA-3  CD58  TS2/9  31.0 
PECAM  l  CD3!  SG 134  0.4 
Thy-- ~  CDw90  5E 10  540,0 
CD44  CD~  Hermes-3  920.0 
CR ~  CD35  J3D3  2.0 
CR2  CD21  HB5  60.0 
CD2  CD2  TS2/18  1.0 
CD45  CD45  562 10D3  9.0 
HLA Class 1I  TSI/16  1.4 
E-selectin  CD62E  H 18/7  -  1.2 
L-selectin  CD62L  LAM 1-3  - 0.8 
P-selectin  CD62P  SZ-51  -  1.4 
CD34  CD34  QBEnd-10  -  0.8 
Sialyl Le x  CD 15s  CSLEX- !  0.0 
Sialyl Le  x  CDI5s  2F3  0.6 
Di-fucosyl SLe  ×  FH6  120.0 
Sialyl I,e  ~  CSLEA--I  1 0 
'Lc  x  CDI5  PM-81  -2.3 
PNAd  MEC ~-79  2.5 
CLA  HECA-452  0.0 
studies (Fig. 2). Neuraminidase treatment and neuraminJ- 
dase  plus  exo-~-galactosidase  treatment  of  rolling  cells 
and substrate did not inhibit cell binding to substrates, ar- 
guing against a role for galactose- or sialic acid-dependent 
interactions. In contrast, hyaluronidase treatment of stro- 
mal cell monolayers and stromal cell matrix decreased celi 
attachment under flow by 98 and 99%.  respectively,  sug- 
gesting that hyaluronan era similar structure may serve as 
a  ligand  on stromal cells  and their matrix.  Treatment  of 
substrates  wit.h  O-g!ycoproteas¢  reduced  cell  attachment 
by  >99%  to matrix and by 53%  to stromal monolayers. 
These results suggest  that there are two classes of struc- 
tures with which hyaluronan is associated on stromal cells, 
one resistant to O-glycoprotease and one whose suscepti- 
bility to this enzyme indicates that it is a glycoprotein con- 
taining O-linked sugar moieties. Stromal cell matrix con- 
tains only the latter class of structures. 
Treatment  of SKW3  cells  with  O-glycoprotease  inhib- 
ited  the interaction with stromaI cells by 98%  and extra- 
cellular matrix by 86%, while the other enzymes had little 
effecL This suggests that the receptor on SKW3 cells is a 
glycoprotein that bears O-linked carbohydrates. 
Rolling Is Blocked by Anti-CD44 mAb and 
Soluble Hyaluronan 
CD44 binds hyaluronan (4, 15, 44, 49, 51) and is suscepti- 
ble to cleavage by O-gtycoprolease  (72).  To determine if 
CD44 mediates rolling on stromal cells, anti-CD44 mAbs 
from the  Fifth  International  Leukocyte  Workshop were 
tested for their ability to block cell attachment and rolling 
(Fig.  3).  Studies  were  done  in  the  presence  of  EDTA. 
BRIC235, 3F12, and A3D8 mAbs inhibited attachment to 
stromal cell monolayers by 52, 38, and 53%,  respectively. 
A  combination of all three mAbs reduced binding to 1% 
of  control  levels,  On  stromat  celi  matrix.  BRIC235  re-. 
duced  binding  by  99%,  while  3F12  and  A3D8  inhibited 
binding by 61 and 94%, respectively. These results suggest 
SKW3 cells use CD44 to roll on stromal cells and matrix. 
To  clarify  the  identity  of  the  hya|uronidase-sensitive 
ligand on stroma! cells~ soluble chondroitin sulfates B and C 
and hyaluronan were tested for their ability to block roil- 
ing (Fig. 3). Binding to stromal monolayers was unaffected 
by chondroitin sulfates B and C; binding lo matrix wa:~ r~ot 
reduced  by  chondroitin  sulfate  B  and  reduced  by  only 
24% by chondroitin sulfate C. Soluble hyaluronan reduced 
binding  under  flow  to  stromal  monolayers  and  stroma~ 
malrix by 96 and 94%, respectively. These results confirm 
that  the  divalent  eation-independenl  roiling  imeractions 
are mediated by CD44 on the rolling celts~ and hyaluron_arJ 
on the substrate. 
Of the three  ~eukocyte  cel| lines used  in this study, ira- 
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t  !  i  '  '  1 
% Centre]  rolling  aUachmems 
b 
I-- 
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#  Neu 
~  V°  ConU'ol 
Neur.+B ! 
% Control rolling  attachments 
Figure  2.  Inhibition  of  accu 
mulation of rolling SKW3 cells 
by  enzyme  pretreatmenl,  (a) 
Stromal ceil monolayers. Con- 
tro! binding of untrealed  cells 
was 86 cells per >~,100 field. @,) 
Stromat  ceil  matrix.  Co~troi 
binding  of untreated  ceils  was 
197  cells  per  ×100  field.  The 
substrate or 0. i %  azide-treated 
SKW3  cei!s  were  ~reatcd  as 
indicated  with  con:rok  mc. 
dium  (Control). neuraminidase 
(Neur.)~  neuraminidase  and 
exo-t3-galactosidase  (Neur +B- 
gal),  O-glycoprotease  (OG), 
or  hyaluronidase  (Hy'dase). 
Ceils  were  accumuiated  at 
0.27, (,.53.0.~0, and 1.1 dynes/cm 2 for 40 s each, followed by rinsing with ceil-flee medium at 1.6, 2A, 2.7, 3,7  4.8.5.8, 7.9, 10.1.  I2.2, 17,5, 
22.8, and 28.1 dyness'cm  2 for 10 s each. Adherent cells were counted after the 0.8 dynes/era 2 accumulation step; all adherent ',;ells rolled 
at higher shear stresses. The mean values of two identical experiments are shown with the ranges indicated by brackets. 
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Figure 3.  Inhibition  of  accu- 
mulation  of SKW3 cells  with 
CD44 mAb and soluble inhibi- 
tors. (a) Stromal cell monolay- 
ers.  Control  binding  was  110 
cells per  ×t00 field. (b) Stro- 
real cell matrix. Control bind- 
ing  was  113  cells per  ×100 
field. Binding of azide-treated 
SKW3 cells was  inhibited  by 
mAb from the CD44 panel of 
the Fifth Leukocyte Workshop 
(BRIC235, 31712, A3D8), chon- 
droitin sulfate B (CS B), chon- 
droitin  sulfate C (CS C), and 
hyaluronan  (HA).  CBRp150/ 
2El  was  used  as  a  negative 
control  mAb.  Experiments 
were in 5 mM EDTA. Adherent cells were counted after the 0.8 dynes/cm2 accumulation step; all adherent cells rolled. The mean val- 
ues of two identical experiments are shown; ranges are indicated by brackets. 
munofluorescence flow cytometry revealed that SKW3 T 
lymphoblastoid and HL-60 myelomonocytic  cells expressed 
high levels of CD44, while Jurkat T  lymphoblastoid cells 
did not express CD44 (data not shown).  HL-60 cells did 
not bind to stromal cells or matrix even though they ex- 
press CD44; similar results have been observed with many 
cells including murine splenic lymphocytes and bone mar- 
row myeloid cells that express high levels of CD44 but do 
not  bind purified  hyaluronan  (44).  Human  peripheral 
blood lymphocytes also failed to bind stromal cells under 
flow  although  they  express  CD44  (data  not  shown),  in 
keeping  with  the  finding  that  resting  human  peripheral 
Control 
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<  EDTA + CS B  " 
,E  EDTA + CS C 
EDTA + HA 
EDTA + p150/2E1 
EDTA + BRIC235 
Control 
OG 
Cor~tro! 
+ EDTA 
Hy'dase 
+ EDTA 
.2 
r~ 
Ceh accumulation  (% controt) 
Figure 4.  Inhibition of accumulation of tonsillar lymphocytes on 
stromal cell matrix. The binding of azide-treated tonsillar lympho- 
cymes was inhibited by 5 mM EDTA, chondroitin sulfate B (CS B), 
cho~.droitin sulfate C (CS C), hyaLuronan (HA), negative control 
mAb CBRpl50/2E1  (pi50/2El).  CD44 mAb BRIC235, and by 
treatment of lymphocytes with O-glyeoprotease (OG) and matrix 
with hyaluronidase (Hy'dase). Control binding of untreated  cells 
was 25 cells per ×100 field. Adherent cells were counted after the 
0.8 dynes/cm  2 accumulation  step; all adherent  cells rolled. The 
mea~ values of two experiments are shown, and the range is indi- 
cated by ~rackets. 
blood lymphocytes do not bind hyaluronan (23, 46).  Hu- 
man T cells can be induced to bind hyaluronan by stimula- 
tion with anti-CD3 for 24 h (23), and murine B ceils can be 
induced  to  bind  hyaluronan  by culture  in  IL-5 or  by a 
chronic graft-vs-host disease in vivo (31, 51, 52). The abil- 
ity of stimulated human B cells to bind hyaluronan has not 
been tested directly, but mitogen stimulation of human B 
cells induces expression of CD44 V6 isoforms that are as- 
sociated in T cells with increased hyaluronan binding (24, 
39). We therefore postulate ~hat the activated cells present 
in tonsillar lymphocyte preparations possess CD44 which 
is capable of binding hyaluronan and it is this difference 
that  accounts for  the  observation  that  tonsillar  lympho- 
cytes adhere  under flow, while peripheral blood lympho- 
cytes do not. 
Tonsillar Lymphocytes Also Use CD44 to Form Roiling 
Adhesions on Stromal Matrix 
We  tested  whether  CD44-hyaluronan  interactions  also 
mediate  the  rolling  of tonsillar  lymphoeytes on  stromal 
matrix (Fig.  4). Treatment of lymphocytes with O-glyco- 
protease reduced adhesion to stromal matrix by .90%. Sol- 
uble hyaluronan and the CD44 mAb BRIC235 completely 
blocked binding  to substrate  in  the  presence  of EDTA. 
Hyaluronidase treatment  of the  substrate  tikewise  elimi- 
nated  binding in  the  presence  of EDTA.  Unlike  SKW3 
cells,  tymphocytes adhered  to  and  rolled  on  the  hyalu- 
ronidase-treated substrate in the presence of divalent cat- 
ions. Thus, additional, cation-dependent mechanisms may 
exist by which tymphocytes interact with these substrates; 
these mechanisms are unlikely to involve selectins for the 
reasons cited above. Taken together,  these  studies  show 
that tonsillar lymphocytes also use CD44 and hyaluronan 
to roll on stromal matrix, but additional cation-dependent 
mechanisms may aiso ptay a role. 
Rolling on Plastic-immobilized Hyaluronan via CD44 
Hyaluronan was immobilized on plastic and used as a sub- 
strate in flow assays to test whether it can support rolling. 
SKW3 cells bound to immobilized hyaluronan under flow 
cGnditions (Fig. 5 a)  Ability of ceils to tether decreased 
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Figure 5.  Accumulation of rolling SKW3 cells on purified hyaluronan. (a) SKW3 cell tethering to plastic-immobilized hyaluronan at var- 
ious shear stresses. Cells were accumulated for 30 s. (b) Inhibition of roiling on hyaluronan plated at 1.0 mg/ml by soluble inhibitors chon- 
droitin sulfate B (CS B), chondroitin sulfate C (CS C), hyaluronan (HA), and CD44 mAb BRIC235. (c) Detachment of cells rolling on hy- 
aluronan plated at 1.0 mg/ml under increasing shear stress. Cells were initially accumulated at .53 dynes/cm  2 shear stress for 30 s. Unless 
noted, cells were not treated with azide; all adherent cells rolled as shear stress was increased. One of two similar experiments are shown 
in a and c, while mean values of two experiments are shown in b with the ranges indicated by brackets. 
with increasing shear.  CD44 mAb  blocked  tethering and 
rolling by 95%, and soluble hyaluronan blocked it by 80%. 
Tethering  and  rolling  were  blocked  by  anti-CD44  mAb 
BRIC235  and  soluble  hyaluronan (Fig.  5  b), confirming 
the  specificity  of these  interactions.  Rolling  interactions 
formed by SKW3 to immobilized hyaluronan were surpris- 
ingly shear resistant (Fig. 5 c). A  minority of cells flattened 
out yet kept rolling; these cells had the highest shear resis- 
tance. Detachment proceeded in a roughly linear manner, 
but complete  detachment was not seen  until shear stress 
reached an impressive 273 dynes/cm  ~. SKW3 cells rolling 
on hyaluronan did not arrest  and form firm  attachments 
like cells rolling on stromal matrix or stromal monolayers; 
azide treatment of the cells was thus unnecessary in these 
experiments and was not done unless noted. 
The rolling velocities of SKW3 cells on stromal mono- 
layers, matrix, and purified hyaluronan were on the order 
of 1 txm/s (Fig. 6). In the case of stromal matrix, mean roll- 
ing velocity decreased  between 7 and 17 dynes/cm  2 shear 
stress, as the majority of cells sped up and detached, leav- 
ing a particularly adherent population behind that contin- 
ued to roll at slow velocities. 
Blocking mAb Recognize Hyaluronan-binding Region 
ofCO44 
To define  the region of CD44 responsible  for mediating 
rolling, a panel of mAbs from the Fifth International Leu- 
kocyte Workshop was tested for their ability to block roll- 
ing on plastic-immobilized  hyaluronan in the presence  of 
EDTA (Table II). mAbs to CD44 have been clustered to 
three distinct epitope groups by competitive inhibition (18, 
1.5" 
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Figure 6.  Rolling velocities of SKW3 cells on different substrates. (a) Stromal cell monolayers. (b) Stromal cell matrix. (c) Hyaluronan 
adsorbed to plastic at 1.0 mg/ml. SKW3 cells used in monolayer and matrix experiments were treated with azide to prevent firm adhe- 
sion through CD44-independent  mechanisms. Cells were initially accumulated at 0.8 dynes/cm  z for monolayer and matrix experiments 
and at 0.5 dynes/cm  2 for hyaluronan experiments, and subsequently subjected to increasing wall shear stresses at 10 s per interval. Val- 
ues were obtained from averaging the rolling velocities of all cells on the field; the SEM is indicated by brackets. 
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Plastic-immobilized Hyaluronan by CD44 mAb* 
mAb  Control accumulation  CD44 epitope:~ 
% 
BRIC235  0  2a  § 
CD44-6B6  41  2 
BU75  45  2a  § 
CD44-9F5  70  2 
50B4  77  2a 
3F12  98  2a  ~ 
HP2/9  100  2a  ~ 
Hermes-3  110  3 
156-3C11  113  3 
KZ1  114  3 
212.3  114  1 
4.C3  116  1 
BRIC222  137  1 
A3D8  154  1 
F10-44-2  330  I 
* Experiment was as described in Fig. 5 legend. 
~- Epitope groups defined by references 18 and 62. 
The mAb shows characteristics that overlap into more than one epitope group. 
62). Some members of epitope group 1 inhibit T cell roset- 
ting (3, 30, 61), while some mAbs of epitope group 3 block 
lymphocyte binding to high endothelial venules (34, 54). 
Epitope 2 contains mAbs  that interfere with hyaluronan 
binding (5); mAb that inhibit hyaluronan binding in solu- 
tion were assigned to epitope group 2a, which is a subset of 
epitope  group  2,  although  this  subset  partially overlaps 
other groups. Five out of seven mAbs in epitope group 2 
and  2a  inhibited  rolling  on  purified  hyaluronan,  while 
mAbs  in group 3  had  little effect, and three out of five 
mAbs in group 1 increased binding. One mAb, F10-44-2, 
greatly increased binding; this mAb also increased binding 
of CD44-transfected, activated Jurkat cells to soluble hy- 
aluronan  (47).  It  was  surprising  that  the  mAb  A3D8, 
which maps to epitope group  1, inhibited attachment to 
stromal cell monolayers and matrix but not to purified hy- 
aluronan (Fig. 3 and Table II). There may be a difference 
in the way purified hyaluronan bound to plastic and hyalu- 
ronan bound to proteoglycans in stromal matrix are pre- 
sented to CD44, such that an antibody that binds outside 
of the hyaluronan-binding region may have an effect on 
the binding of cells to one substrate but not to the other. 
Dermal Fibroblasts But Not A-431 Cells or HUVEC 
Support Hyaluronan-dependent Rolling of SKW3 Cells 
To determine if other cell types produce hyaluronan-like 
ligands  that  are  capable  of  supporting  rolling,  we  ex- 
panded our flow chamber studies to include dermal fibro- 
blasts, the epithelial cell line A-431, and HUVEC. 
SKW3 cells formed hyaluronan-inhibitable rolling inter- 
actions with monolayers of dermal fibroblasts and  their 
matrix (Fig. 7 a). However, binding to dermal fibroblasts 
was twofold lower than binding to stromal cell monolayers. 
A-431 monolayers supported SKW3 cell attachment at a 
level fourfold lower than stromal cell monolayers (Fig. 7 a). 
These interactions were  not  inhibited  by EDTA,  chon- 
droitin sulfate B, or hyaluronan, and thus seem unlikely to 
involve CD44. SKW3 cells did not bind to A-431 matrix. 
HUVEC  monolayers were tested either under resting 
conditions or after stimulation with TNF-et for 24 h. While 
we  did observe rolling of SKW3 cells on TNF-a-stimu- 
lated HUVEC monolayers at a level twofold higher than 
on stromal cell monolayers, these interactions were com- 
pletely blocked by EDTA and unaffected by soluble hy- 
aluronan (Fig. 7 b). Furthermore, no interactions of SKW3 
cells were seen with the matrix of either stimulated or un- 
stimulated HUVEC, nor with unstimulated monolayers. 
Divalent Cation-sensitive Aspects of SKW3 Cell 
Interactions with Stromal Cells 
Although the CD44-hyaluronan ligand pair are clearly ca- 
pable of mediating cell rolling, the number of rolling adhe- 
sions  formed  by  SKW3  and  tonsillar  lymphocytes  de- 
creased  in  the  presence  of  EDTA.  When  SKW3  cells 
bound to stromal matrix in the presence of divalent cat- 
ions at 0.3-0.5 dynes/cm  2, rolling was not evident. When 
shear stress was increased to 0.8 dynes/cm  2, ~15% of ad- 
herent cells began to roll. When shear stress reached 1.1 
dynes/cm  2, the majority of cells rolled (Fig. 8). In the ab- 
sence of divalent cations, fewer cells adhered to the sub- 
strate at 0.3-0.8 dynes/cm  2, and those that did adhere be- 
gan  rolling  immediately.  When  EGTA  and  Mg  2÷  were 
used in the assay instead of EDTA, cells that adhered also 
began rolling immediately, suggesting that the initial firm 
adhesion seen in the presence of divalent cations was Ca  2÷ 
dependent. To examine these effects, we conducted anti- 
body-blocking studies in the presence of divalent cations. 
BRIC235 CD44 mAb inhibited binding of SKW3 cells to 
stromal matrix by 95%  (Fig. 9). However, in the absence 
of CD44 mAb, mAb to the 131 integrin subunit inhibited 
binding of SKW3 cells to stromal matrix by 50%; EDTA 
inhibited binding by a similar amount, mAb to the 131 inte- 
grin subunit, like EDTA, also abolished stationary, non- 
rolling adhesion of cells to stromal cell matrix under low 
shear  (Fig.  8).  131  blockade  has  an  effect equivalent  to 
EDTA in blocking binding to matrix (Figs. 8 and 9), sug- 
gesting that 131 integrins mediate the majority of cation- 
dependent interactions with this substrate. Comparison of 
blocking mAb to integrin et subunits showed inhibition of ad- 
hesion to stromal matrix only by mAb to the a6 subunit 
(Fig. 9 b). The a6131 integrin did not appear to play a role 
in initial cell tethering to substrates because binding under 
flow was negligible after hyaluronidase treatment of both 
stromal monolayers and matrix (Fig. 2), and, as mentioned 
above, mAb to CD44 almost completely blocked binding. 
However, the et6131 integrin clearly participated in strength- 
ening adhesion to the substrate  once contact was  estab- 
lished, mAb to the 131 integrin subunit had less effect on 
binding  to  stromal  cell  monolayers,  inhibiting  by  only 
25%. In addition, 20% of tethering and rolling of SKW3 
cells  on  stromal  cell monolayers  was  not  blocked  by  a 
combination of mAb to CD44 and the 131 integrin subunit, 
suggesting that other divalent, cation-dependent adhesion 
interactions contributed to binding to monolayers. 
Tonsillar Lymphocytes and Lymphoblastoid Cells Roll 
via CD44 on Frozen Sections of Human Tonsil 
To  study  the  interactions  of tonsillar  lymphocytes  and 
SKW3 cells with tonsillar stromal cells and  their matrix 
products in situ in the tonsil, freshly cut frozen sections of 
C/ark et al. CD44-mediated Lymphocyte Rolling on Hyaluronan  1081 Figure Z  Formation of rolling interactions of SKW3 cells with monolayers and matrix of various cell types. (a) Tonsillar stromal cells~ 
dermal fibroblasts, and A-431 cells, (b) HUVEC with and without stimulation with 201) U/ml TNF-a for 24 h. Interactions of azide- 
treated SKW3 cells with monolaye~ or the ECM after monolayer removal were inhibited with chondroitin sulfate B (CS B), chondroitin 
sulfate C ((2S C), and hyaluronan (HA). Adherent cells were counted after the 0.8 dynes/cm  ~  accumulation  step; all adherent cells rolled 
as shear was increased. Results shown are from one of two similar experiments. 
human tonsil were used as the substrate for rolling experi- 
ments. The locations of T  cell and B cell areas, HEV, and 
reticular fibers in the T  cell areas could be identified by 
light microscopy and were verified by fluorescent staining 
of serial sections. In the presence of divalent cations, ton- 
sillar lymphocytes and SKW3 cells bound under flow to 
both HEV, as evidenced by ringlike accumulation of cells 
in the T cell areas, and also to other structures in the T cell 
areas and near crypts. Under increasing shear, cells bound 
to  putative HEV  detached,  while those  bound to  struc- 
tures in the T  cell areas were able to roll a  considerable 
distance along the section. When EDTA was included in 
the  experiments,  binding  to  HEV-like  structures  was 
greatly attenuated, while binding to other structures in the 
T  cell areas and near crypts was only partially inhibited. 
Tonsil lymphocytes and SKW3 cells behaved similarly, but 
SKW3 cells were more easily visually discriminated from 
the underlying frozen section because of their larger size. 
In regions of the tonsil where reticular fibers were visually 
discernible, cells were observed to roll along single fibers 
oriented parallel to the direction of flow. When a fiber di- 
verged from the direction of flow, cells were seen to pause 
at  that location, and then either detach under increasing 
shear or transfer onto a  neighboring fiber (Fig. 10 a).  In- 
clusion of EDTA  in the  assay decreased  the  number of 
SKW3 cells stably rolling across  the  section from 234 to 
220 cells and eliminated the  transient adhesions of cells 
seen in the prese~,ce of divalent cations (Fig. I0 b). How- 
Figure 8,  Binding of SKW3 ceils to stromal cell matrix.  Adhesion of azide-treated SKW3 cells to matrix was done in the presence of 2 
mM Ca  2+ and 1 mM Mg  2  ~ and no inhibitors (a) or the 131 integrin subunit mAb Mab 13 (b) or 10 raM EDTA (c). A celt was designated 
as "stationary" if its roiling velocity was <0.25 ixm/s. Results are from one of three similar experiments. 
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trix.  Control  binding of un- 
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5  mM  EDTA,  CD44  mAb 
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BRIC235 mAb aione; by [a,i 
integrln mAi:.. Mab 13 ([5I mAb): and by mAb to the inlcgrm (~: iB3.1 (~1 mAh). Gi9 i~2 mAb). 3143 (~3 mAi)), PUJ4 (~4 mAb). PUJ5 
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~r,  ear was ip.crcased The mea~? values of two ideotical expcrime,;ls arc sh~wn: rarges are indicated by brackets, 
ever, treatmen{  of SKW3 cells with mAb BRIC235  or hy- 
aiuronan redueeo tethering and rolling along ti~e fibers ir, 
the pre~ence  of EDTA  to si~ and  five cells, respectively 
(Fig.  ]('.'. c  and  d).  A  seriai section stained  with  coliager, 
type: IX,; mAb confirmed that the field containe0 an exten 
sire network hi reticular fibers (Fig. 10. e and ¢3. Tonsillar 
lymphocytcs attached and  roiled along reticular fibers at 
lower levels than SKW3 cells, in one representative exper.. 
imem. 4(~ tonsillar lymphocytes bound  per  ×100  field in 
the presence of divalent cations, 2! cells bound in the pres- 
ence of EDTA. and no cells bound when BRIC235 o~  h>'- 
aiuronan  were  combined  with  EDTA  (data  net  simwn). 
These experiments illustrate that tymphocy~es are abk" t~ 
bind and  lol~ aiong struclures actually pre,~enl i~  the  h~> 
man tonsil usinp the CD44-hyaluronan ime,act~on exar:, 
meal m  tl~is :<.~t~d\, 
Discussi~.n 
Our studies demonstrate tba~  stromai eelis cuttured from 
human  tonsil produce hyaluionan-comaining ligands thal 
suppor~  CD44-dcpendent  iymphocyte telhering and  ro!t. 
i~g. The ligand for CDa4  was identified as hvaiuronan  b T 
its sensitivity to hyaluronidasc, by inhibition with soluble 
hyaiutonan,  and  by  rcconstitution  of  CD44-dependem 
binding and rolhng on substratcs bearing immobilized lz\,- 
ahmman  CD~4 has been previousiy showp., to bind hyala 
ronaI: in static assays ,.,4, t5.44, 4% 51)  i-~ya!uronan is pr~> 
duced I;y hbroblast~ and ot]~er cells as a soluble molecul~.: 
on the inner surface of the plasma membrane and is l~ar~s-- 
ie~e:d imo  the  periceiiui~;i space, daring synthesis (57)~  J~ 
tan  remain  bound  to  cells d~recti'r', presumably  througL 
cominucd  a|tachment  lo  the  sv~thase  (56)  or indirectly, 
viii  hyaluronan-bindieg  prolems  (37).  Ou~  s!udie~  show 
tha,~  hya~v, onan-iike  iigands  produced  L~ 3,  st:omal  ceils 
v~e:c  r~rese,ni  both  on  l i~c  col!  surface  and  incorporated 
iot(, tbc  E¢:M. W~ ioilnd Iwo separate classes o{ ass(,cia- 
t~on o{ CD44 iigands will~, the surface of stromal cells. One 
t. a.. was  ...........  q. ,',  susceplibie to cleavaee i~v O-elvcoprotease. s~a- 
geslmg the  structme lhal associaled hvahuonan  wilh  the 
ce?{ smf<c:  contained  ()Amked glycam..  O~e  such  moi,: 
cuJe is CD44  itseli, which is highly expressed by stromal 
cells. Hyaluronan  produced  by  the  stromal  cells may be 
immobilized and presented on the cell surface t~y stroma] 
cell CD4a. The O-glycoprotease-insensitive ligand activity 
on stromal ceils may represent either hyaluronan directly 
associated with the stromal cell membrane or bound to ar~ 
other uncharacterized structure on the cel! surface. O-g~y- 
coprotease  treatment  of stromal  cell  ECM  almost  com. 
pletely removed ligand activity. The structure with which 
hyaluronan associates m  the stromal cell ECM is unlikely 
to be CD44  because fluorescent s|aining of the ECM  ie-. 
veafed  CD44  was  presenl  only  in  membrane  fragment: 
that remained after cell removal This CD44 was not dis- 
tri0uled  in  a  continuous  manneT  and  seemed  unlikely ~c', 
support the sustained rolling that was observed (data nt;: 
si~own). Severai ECM  components are known to brad Ly- 
almonan,  inctudine.,  the  cartilage oroteins,  aggrecan  ~50~.., 
and  hnk  protein  (27)  and  the  fibmblast protein vcrsica~ 
(43). Fiuorescenl s~aming of the stl omai cell ECM 6emo~1- 
straled a laminar deposition of versican, and this protein 
also a componem of the reticular fibers of the lymph n,,dc 
and tonsil (data not shown). Versican contains pulaliv.,: .'.~: • 
tacmnent  sites  for  both  N-  and  O-iinked  carbohvdra!~s 
(781.  but  the susceptibility of this protein to O-gb.cop~o- 
~ease is not known. Our' findings sugges*,  that the proteit;s 
~esponsibIc l'ot  assembly of hyaluronm~  in  the  matrix  :~f 
slroma] ceils possess 0oth the hyalmonan-binding proper- 
tic  °:  of protem~  .qke  ve'csica~ and  O-glycepr~lea~,c--.:.ensi 
me. muein-iik~: ~cgJo':~s 
Although bloc; h!~_' hi CDdd-nyaturonan interact~ona b:/ 
tithe:  CD44  mat;  ~?r  hyalu:omdase  lreatmen~  almo~': 
comNcteiy inhibited tethering to stroma] subslr ales unde; 
shear suess, the ~66t  integrin  was sccn  lo participaee i,. 
z~di~esion by slabihzing the binding, ol adherem ceiis to ~i~(: 
subsuai,:,  mAb  ~¢:  lhe  c~-, and  131  intcgrm  subunik,  d~- 
creased  celt  attachment  to  st~omat  celi  monolayers  ant! 
matrix and eausee a6~rerent cells to begin roiimg a*. iow,:r 
,,..hear slresse,:. CDa4--hyaluronan interactions appeared io 
rnediatc:  inilia}  ccH  lethering  under  sheal  sues.-,  whi~c 
~6[~,i  increased the avidity of bindw.g, thereby dccreasir~ 
tk~e roiime velocity o~: ceils and enhancing c~ It binding by 
Clark e: a! ("  .'44-m~diatc3  I,ympho~ yte 5'o/!ing m:  ffr ~.; t,," .? v:  Og3 Figure 10.  Video images of SKW3 cells rolling on frozen sections of human tonsil. (a) Cell adhesion and rolling in the presence of diva- 
lent cations. (b) Adhesion and rolling in presence of EDTA. (c) Inhibition of adhesion with CD44 mAb BRIC235 and EDTA.  (d) Inhi- 
bition of adhesion with soluble hyaluronan and EDTA.  Counts of adherent cells were made from the videotape with the full field of 
vie~v; only a portion of the field is shown. SKW3 cells were not treated with azide. (e) Serial tonsil section stained with collagen type IV 
mAb M138. The photo represents only part of the field shown in a-d; the region shown is outlined in f. (f) The same field as shown in a-d 
averaged over 50 frames in 5 s so that images of rolling cells are lost. The area shown in e is outlined. 
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transiently to remain adherent. The complementary rela- 
tionship of these two adhesion systems is similar to that 
proposed for the selectins, which mediate binding under 
shear  stress,  and  integrins  such  as  LFA-1  and  Mac-l, 
which mediate firm adhesion once contact between cells 
and rolling substrates has been established (42). However, 
we suppressed development of true firm adhesion in our 
experiments by treating cells with azide. This allowed for 
weaker integrin-dependent adhesion that did not prevent 
cells from rolling when the wall shear stress was increased 
above 1 dyne/cm  z. 
Dermal fibroblast monolayers and ECM but not HU- 
VEC endothelial or A431  epithelial monolayers or their 
secreted ECM supported hyaluronan-dependent lympho- 
cyte rolling. SKW3 cells bound under flow and rolled on 
monolayers and matrix of dermal fibroblasts at lower lev- 
els  than  that  seen  with  cultured  tonsiUar  stromal  cells. 
Stromal cells of the secondary lymphoid organs may be 
specialized to produce high levels of hyaluronan, a charac- 
teristic in keeping with the production of reticular fibers. 
The  findings  with  HUVEC  are  surprising  given  that 
CD44-hyaluronan  interactions  mediate  binding  to  cul- 
tured endothelium in static assays in both the human and 
mouse (4, 45, 66). Additional studies are needed to deter- 
mine if hyaluronan produced by cultured endothelium is 
able to bind CD44 in static assays but not under conditions 
of flow. 
The first step in lymphocyte recirculation involves the 
entry of cells into the secondary lymphoid organs by trans- 
migration  through  HEV.  CD44  has  been  implicated  in 
lymphocyte extravasation by studies in which binding of 
lymphocytes to HEV of human frozen sections was inhib- 
ited by the CD44 mAb Hermes-3 and by polyclonal anti- 
sera raised against CD44 (34). However, Hermes-3 did not 
block  hyaluronan-dependent adhesion  of a  CD44-trans- 
fected B cell line to cultured rat endothelium (66), and this 
mAb recognizes a portion of the CD44 molecule that is 
not required for hyaluronan binding (28, 32, 55). These re- 
sults  suggest  that  the  observed binding  to human  HEV 
may not be hyaluronan dependent. In the mouse, lympho- 
cyte  binding  to  HEV  was  insensitive  to  hyaluronidase 
treatment and mAb known to block CD44 binding to hy- 
aluronan (15). Adhesion to mouse HEV was found to be 
mediated  by  L-selectin  binding  to  carbohydrates  other 
than  hyaluronan  (45).  Moreover,  human  lymph  nodes 
treated with CD44 chimera gave weak definition of HEV 
but intense reactivity with connective fibers organizing the 
parenchyma (4), indicating that hyaluronan is expressed 
more highly in reticular fibers than in HEV. The low ex- 
pression of hyaluronan on lymph node HEV, the lack of 
clear mAb  blocking data,  and  the findings of this study 
that HUVEC monolayers do not support CD44- and hy- 
aluronan-dependent rolling raise questions as to whether 
CD44 interactions with hyaluronan play a role in lympho- 
cyte extravasation. 
After entry into the  secondary lymphoid organs, lym- 
phocytes migrate to specific T and B cell areas to contact 
distinct classes of antigen-presenting cells. To examine the 
possible  contributions  of CD44-hyaluronan  interactions 
to migration within secondary lymphoid organs, we devel- 
oped an assay in which cells bind under conditions of flow 
to frozen sections of human tonsil. This assay resembles 
the Stamper-Woodruff assay (67) in that it uses frozen sec- 
tions but has the additional advantage of isolating interac- 
tions that are capable of mediating tethering and rolling 
under flow. We observed divalent cation-independent ad- 
hesion and rolling along reticular fibers in the T cell areas 
of the tonsil section that were blocked by hyaluronan or 
CD44 mAb. Because reticular fibers are always closely as- 
sociated with stromal cells (14), it was impossible to tell if 
cells rolled along the stromal cells themselves or the retic- 
ular fibers. However, our results with cultured cells show 
that cells roll on both stromal cells and their ECM prod- 
ucts via CD44, so both structures probably present hyalu- 
ronan to rolling cells. These findings lend credence to the 
hypothesis that reticular fibers act as a scaffolding for the 
migration of lymphocytes throughout secondary lymphoid 
organs (14, 38). 
We speculate that the observed transient interactions of 
lymphocyte CD44 with the hyaluronan of secondary lym- 
phoid organs may support the migration of lymphocytes as 
they transit through these sites in search of specific anti- 
gen. Production of hyaluronan is known to be increased at 
sites  of  cell  migration  (41),  and  this  carbohydrate  sur- 
rounds migrating and proliferating cells in areas of tissue 
remodeling, regeneration, and  healing (73).  It has  been 
suggested that hyaluronan aids cell migration by creating 
hydrated pathways  that  assist  cell penetration of tissues 
(73) and also by directly stimulating cell locomotion (74). 
Moreover, the dynamic nature of the interactions we ob- 
serve between lymphocytes and hyaluronan are intriguing 
in light of current models of cell migration. A  crucial as- 
pect of cell migration is the dynamic reversibility of bonds 
formed between a  migrating cell and the  substrate  (22). 
The fact that lymphocytes bind to hyaluronan under flow 
and then roll under moderate shear stresses suggests that 
this ligand pair can rapidly establish bonds that are strong 
enough to maintain cellular contact with the substratum 
but  not  strong  enough  to induce permanent  cell arrest. 
Studies of migration of smooth muscle cells on the ECM 
ligands  fibronectin and type IV collagen found that cell 
migration  speed  was  fastest  at  intermediate  attachment 
strengths (19). Empirical and theoretical findings suggest 
that migration speed is biphasic with respect to attachment 
strength: low attachment strengths do not allow the motile 
force within  the  cell to  be  transmitted  to the  substrate, 
moderate attachment strengths produce fastest migration, 
and  high  attachment  strengths  result  in  cell  arrest  and 
spreading (19, 40). Based on these findings, it is possible 
that  the  transient  rolling interactions we  have  observed 
between lymphocytes and hyaluronan may reflect an abil- 
ity of this ligand pair to support cell migration. 
Although  we  do not  propose that  the  interaction be- 
tween CD44 and hyaluronan supports rolling in vivo, its 
ability to do so in vitro may be instructive nonetheless. 
The mechanical stability of a bond, i.e., a small rather than 
large effect of hydrodynamic drag force on the off-rate of 
a bond, as well as fast on- and off-rates, have been shown 
to be important for selectin-mediated rolling  (1). These 
characteristics may apply to the CD44-hyaluronan bond 
as well. Mechanical strength is thought to be an important 
characteristic of the ECM, and it may be that, given suffi- 
ciently high on- and off-rates, other ECM receptor-ligand 
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flow.  For  example,  the  interaction  of the  ECM  protein 
laminin with the integrin 0L6134 also supports rolling (75). 
Adhesion in shear flow may therefore prove to be an in- 
teresting assay in which to examine the mechanical charac- 
teristics of ECM-receptor bonds. 
In conclusion, we  demonstrate  that lymphocytes  form 
CD44-  and  hyaluronan-dependent  rolling  interactions 
with cultured tons]liar stromal cells, stromal cell ECM, pu- 
rified hyaluronan, and reticular fibers in the T cell areas of 
secondary lymphoid organs. Lymphocyte migration through 
secondary lymphoid organs is likely to be a complex pro- 
cess  involving many  adhesions  systems.  We  predict  that 
the  hyaluronan-CD44  interactions  examined  here  may 
participate in this process, but a full description of this in- 
tricate behavior awaits further study. 
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